This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Gregory J. Wilson: Innovator in Reovirus Vaccines
Introduction
Gregory J. Wilson is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of immunology through his innovative work on reovirus vaccines. His research focuses on developing modified reoviruses that can elicit immune responses against various pathogens.
Latest Patents
Wilson holds a patent for "Reovirus vaccines and methods of use therefor." This invention provides modified reoviruses that carry α-helical epitopes from a variety of pathogens. The methods outlined in the patent aim to generate immune responses against these epitopes in hosts, showcasing Wilson's commitment to advancing vaccine technology. He has 1 patent to his name.
Career Highlights
Gregory J. Wilson is affiliated with Vanderbilt University, where he conducts his research. His work has garnered attention for its potential impact on vaccine development and public health. Wilson's innovative approach to utilizing reoviruses represents a significant advancement in the field of immunology.
Collaborations
Wilson collaborates with esteemed colleagues, including Mine Ikizler and Karl W. Boehme. These partnerships enhance the research efforts at Vanderbilt University and contribute to the development of effective vaccine strategies.
Conclusion
Gregory J. Wilson is a pioneering inventor whose work on reovirus vaccines has the potential to transform immunological practices. His contributions to the field are invaluable, and his ongoing research continues to inspire advancements in vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile